The misuse of Bacillus anthracis as a bioweapon continues to be a serious concern. Medical personnel and researchers are served well if appropriate non-pathogenic anthrax simulants can be used as countermeasures in preparative planning. While there are several accepted simulants of B. anthracis, the addition of another model organism would be beneficial. This investigation was undertaken to evaluate the suitability of B. pumilus as a simulant for B. anthracis. All organisms were grown on AK Agar #2 to foster sporulation. Optimum conditions for spore formation were determined for B. pumilus as well as for currently used anthrax surrogates B. atrophaeus and B. thuringiensis. Spore dimensions were determined by scanning electron microscopy. Comparative antibody binding studies using commercially available anti-Bacillus antisera were completed with the simulants as well as with a negative control organism, Clostridium sporogenes. We report that B. pumilus sporulated readily (2.9 × 10 10 viable spores per plate), had appropriate spore size (1.24 μm × 0.59 μm) and reactivity with anti-Bacillus antibodies. The characteristics of B. pumilus determined in this study suggest this organism represents a novel, suitable model for B. anthracis.
Introduction
The intentional use of a biological agent resulting in morbidity or mortality represents a real and on-going threat [1] . Bacillus anthracis is considered a leading candidate as a biological weapon [2] . One of the characteristics of B. anthracis that makes it an attractive bioweapon is its ability to form spores in harsh environments and subsequently germinate when conditions become favorable. Survivability of dormant spores is remarkable. Spores of B. anthracis recovered from dirt retained lethality in guinea pigs after 60 years [3] .
Exposure to aerosolized B. anthracis spores could result in inhalational anthrax, a disease that approaches nearly universal mortality if left untreated [4] . The farreaching implication of bioterrorism involving anthrax in the US was demonstrated by delivery of B. anthracis spores through the mail, resulting in over 1000 individuals being considered at risk of exposure [5] .
The seriousness of anthrax dictates that investigations into new technologies for detection of anthrax spores continue. Due to the virulent nature of B. anthracis, strict adherence to safety protocols must be followed. Inactivation of spores from B. anthracis may result in alterations in antigenic structures or changes in targeted nucleic acid sequences that may affect detection [6] . To permit more thorough investigation of possible detection methodologies, it is often desirable to use spores from other Bacillus spp. that can serve as models for anthrax spores. The Bacillus cereus group, a genetically closely related group of Bacilli, is comprised of B. anthracis, B. cereus, B. mycoides, B. thuringiensis and B. weihenstephanesis [7] . From this group, B. cereus and B. thuringiensis have been used as surrogates for B. anthracis [8, 9] . Other Bacilli have also been used as simulants including B. atrophaeus and B. subtilis [10] [11] [12] . Bacillus pumilus has been phylogenetically placed within the branch for B. subtilis, an accepted simulant, based on the sequencing of 16S rDNA [13] . Several criteria have been suggested when considering an appropriate organism to model B. anthracis including virulence, genetic and morphologic similarity to B. anthracis, and how the simulant responds to challenges from chemicals or the environment [14] . Bacillus anthracis has been well-characterized and spore dimensions have been reported [11] .
This investigation was undertaken to determine suitability of B. pumilus as a simulant for B. anthracis. Bacillus pumilus was chosen for study for several reasons, including lack of virulence, ease of growth and sporula-tion as well as its genetic relatedness to other model organisms. Since spore sizes for B. pumilus have not been reported, this study is the first to provide spore dimensions. Bacillus pumilus is an environmental organism and has been investigated primarily for commercial application of various enzymes it produces [15, 16] 
Materials and Methods

Organisms and Spore Preparation
Organisms used in these studies included Bacillus atrophaeus (ATCC #9372), B. thuringiensis (ATCC #10792) and B. pumilus (ATCC #700814). Clostridium sporogenes (ATCC #3584) was used as a negative control for antibody binding studies. All organisms were inoculated into 5 ml T-soy broth and incubated overnight at 35˚C. Clostridium sporogenes was kept under anaerobic conditions for all manipulations. One hundred μl of each broth was spread onto nutrient-deficient AK Agar #2 plates (Becton, Dickinson and Company, Sparks, MD), sealed with parafilm and incubated at 30˚C. For B. atrophaeus, B. pumilus and Cl. sporogenes, plates were evaluated daily for sporulation through 10 d post-inoculation. Samples from B. thuringiensis were evaluated daily through 20 d post-inoculation. Optimum sporulation was considered to have occurred when 90% -95% of organisms had formed spores. Determination of sporulation was made by Schaeffer-Fulton spore stain and light microscopy.
After appropriate incubation, 10 ml of cold phosphate buffered saline was added to each plate for 5 min to loosen spores. Spores were scraped off plates using a sterile loop. The spore suspension was pelleted by centrifugation in a 15 ml centrifuge tube. The pellet was resuspended in 1 ml of sterile deionized water (dH 2 O) and transferred to a 1.5 ml microfuge tube. Spores were washed at least five times with dH 2 O. The washed spores were resuspended in 1 ml of dH 2 O and heated in a heat block to 65˚C for 30 min to destroy any vegetative cells. After a final wash, spores were resuspended in 1 ml of dH 2 O and stored at 4˚C.
Spore counts were determined in two ways. Viable counts were determined by spreading dilutions on T-soy agar plates and counting colonies after overnight incubation. Total direct counts were done in a hemocytometer using a phase-contrast microscope. All counts were done at least three times and averages ± SE were determined.
Electron Microscopy
In preparation for electron microscopy, an aliquot of each spore stock was washed three additional times in dH 2 O and diluted in dH 2 O resulting in 10, 100 or 500 spores μl -1 . One μl of each dilution was placed on an aluminum specimen stage and allowed to dry completely under a laminar flow hood. The spores were coated with an 8 nm layer of gold (Hummer 6.2 Sputter Coater, Ladd Research, Williston, VT) prior to scanning in a Hitachi SEM 3400 (Hitachi High-Technologies, Tokyo). An accelerated voltage between 15 and 20 kV was applied. A minimum of 100 spores from each organism were evaluated. Image J software was used to measure spores [17] .
Microarray Preparation and Detection
In order to evaluate multiple antibodies binding with spores from different organisms, spore microarrays were developed. In this process, spores from each Bacillus spp. and Cl. sporogenes were applied to slides as an array. Appropriate spore dilutions of each organism were prepared in spotting solution (ArrayIt, Sunnyvale, CA) such that 100 spores were applied in triplicate as a microarray to an epoxy-coated slide. Microarrays were prepared with a SMP8 pin guided by a SpotBot microarray robot (ArrayIt). The microarray was allowed to air dry at room temperature for at least two h. The slide was heated at 95˚C for 25 min to ensure fixation of the spore samples to the slide. The slide was placed in a UV crosslinker (Spectronics Corporation, Westbury, NY) for two cycles (6500 μJ·cm 2 -1 ) to deactivate any remaining epoxy functional groups. The slide was washed with 0.1% sodium dodecyl sulfate (SDS) for 5 min followed by washing with dH 2 O for 3 min. ArrayIt blocker was applied to the edge of the slide and a coverslip was placed over it yielding 1 µl blocker mm 2 -1 coverslip. The slide was incubated at room temperature for one h, after which the coverslip was removed for additional SDS and dH 2 O washes and drying cycles performed in the same manner as described above.
The primary monoclonal anti-B. anthracis was obtained from Virostat (Portland, ME). All other primary anti-Bacillus antibodies were purchased from Tetracore (Rockville, MD). Secondary fluorescently labeled antibodies were acquired from Jackson ImmunoResearch Laboratories (West Grove, PA). Primary antibody was diluted 1:50 in a 1:1 mixture of dH 2 O and blocker and added to the array and covered with a coverslip as 1 μl antibody dilution mm 2 -1 coverslip. The slide was incubated at 35˚C for 30 min. Following incubation, the slide was washed with 0.1% SDS and dH 2 O as before. The secondary fluorescently labeled antibody was diluted 1:100 and applied, incubated and washed in identical fashion as the primary antibody. The dry slide was analyzed for fluorescence using a confocal laser scanner (Genetix Ltd., Queensway, Hampshire, UK).
Results
percent viability among the Bacilli was similar, ranging from 59 -64. Clostridium sporogenes spores exhibited a lower viability at 36%.
Sporulation
AK Agar #2 proved to be an ideal medium to promote sporulation for most organisms used in these studies. Bacillus pumilus yielded the highest number of spores, for both viable plate count (2.92 ± 0.19 × 10 10 ) and total direct count (4.58 ± 0.42 × 10 10 ) ( Table 1 
SEM Spore Comparisons
Electron micrographs of each of the Bacilli are seen in Figure 1 . Spores of each Bacillus were measured using Image J. Length and width dimensions are summarized in Table 2 . Table 2 also lists spore dimensions reported by others. The values for each of the Bacilli investigated in this study represent averages ± SE of a minimum of 100 spore measurements. Bacillus atrophaeus spores were 1.314 ± 0.018 μm in length and 0.752 ± 0.013μm in width. Bacillus pumilus spores were 1.242 ± 0.022 μm Cl. sporogenes 6 1.02 ± 0.14 × 10 in length by 0.594 ± 0.016 μm in width. Bacillus thuringiensis spores were 1.580 ± 0.024 μm in length and 0.754 ± 0.022 μm in width.
Serologic Reactivity
When evaluating a potential anthrax simulant organism, it is important to consider how the organism lends itself to detection. Binding with antibody through immunoassays is a common approach for detection. Both polyclonal and monoclonal commercially available antibodies were used to evaluate binding among the organisms in this study. All polyclonal antisera bound with the Bacilli under investigation ( Table 3) . No binding occurred between any anti-Bacillus antisera and the negative control Cl. sporogenes. The monoclonal anti-B. anthracis was highly specific and failed to bind with any Bacilli used in this study. Similarly, monoclonal anti-B. thuringiensis was specific and bound only with B. thuringiensis. Bacillus pumilus displayed reactivity patterns in almost identical fashion as B. atrophaeus and even bound with monoclonal anti-B. atrophaeus.
Discussion
It is likely that the potential for misuse of B. anthracis as a bioweapon will continue. This threat requires vigilance on the part of medical and research personnel. Due to biosafety and containment issues, it is highly desirable to use organisms that can serve as model simulants for B. anthracis as new detection technologies are developed. Bacillus pumilus shows promise as a new anthrax surrogate. AK Agar #2 was an ideal medium to promote sporulation for B. atrophaeus, B. pumilus and Cl. sporogenes. Bacillus pumilus produced the highest number of spores of all organisms in this study. However, AK Agar was not as effective at promoting spore formation for B. thuringiensis. With this medium, B. thuringiensis yielded the lowest number of spores and required 16 days to achieve 90% sporulation. Successful sporulation of B. thuringiensis has been reported using nutrient broth yeast extract agar [9] , T-soy agar supplemented with 5% sheep blood [6] and sporulation medium S [18] .
The percent viability exhibited by the Bacilli cultured on T-soy agar following spore formation on AK Agar #2 was similar with an average just over 60%. In our hands, Cl. sporogenes was nearly half that at 36%. Yang reported [19] that the viability of Cl. sporogenes cultured on T-soy was 30%.
Some variability is evident among reports of spore sizes ( Table 2 ). An explanation for this variation may be the amount of water remaining in the spore during preparation [20, 21] . Additionally, the method used to determine spore dimensions would impact measurements. Spore dimensions reported by Buhr [22] were based on phase microscopy. Scanning electron microscopy has been used [23, this study] and Carrera [11] used transmission electron microscopy. The measurements made by Plomp [21] , resulting in the largest reported spore sizes, were based on atomic force microscopy. Spore dimensions for B. atrophaeus in this study (1.31 × 0.75 μm) are in agreement with other reports [11, 22] (1.22 × 0.65 μm and 1.21 × 0.68 μm, respectively). Our measurements for B. thuringiensis were also similar with dimensions reported by Carrera [11] (1.58 × 0.75 μm vs 1.61 × 0.80 μm). To our knowledge, this is the first report of spore dimensions for B. pumilus. One criterion for an appropriate simulant for B. anthracis is spore size [14] . Carrera reported [11] that spores of B. anthracis fall into two size categories, a larger size of 1.49 -1.67 μm × 0.81 -0.86 μm and a smaller spore size of less than 1.26 μm × 0.81 -0.86 μm. We determined that B. pumilus spores represent the smaller sized category with dimensions of 1.24 × 0.59 μm.
There are risks associated with working with B. anthracis and inactivation of spores by heat, chemicals or radiation may alter antigenicity [6] . Many detection assays are immunologically centered. An inherent problem with antibody based detection is the high level of crossreactivity that occurs among Bacilli, particularly when using polyclonal antisera [24] [25] [26] . Such cross-reactivity was evident in the current study ( Table 3) . Based on our Bacillus pumilus also may represent a useful anthrax simulant since it is rarely implicated as a cause of disease. There is one report of B. pumilus being responsible for cutaneous infection in humans [27] . In that report, the authors noted that the lesions were similar to lesions that occur during cutaneous anthrax infection. However, it was also stated that infection of humans by B. pumilus was "exceptional". Bacillus pumilus seems to represent an appropriate organism to model B. anthracis. It sporulates to high titer readily, produces spores of similar size as B. anthracis and may be considered a non-pathogenic organism.
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